Avricore Health (AVCRF) Amortization of Deferred Charges (2020 - 2021)
Avricore Health (AVCRF) posted quarterly Amortization of Deferred Charges of $30369.8 for Q1 2021, up 235.72% YoY from $9046.2 in Q1 2020, and down 13.79% sequentially from $35226.2 in Q4 2020.
Avricore Health (AVCRF) Amortization of Deferred Charges (2020 - 2021) Analysis & Trends
Avricore Health has disclosed Amortization of Deferred Charges across 2 years of filings, most recently posting $30369.8 for Q1 2021.
- In Q1 2021, Amortization of Deferred Charges rose 235.72% year-over-year to $30369.8; the TTM figure through Dec 2021 stood at $30369.8 (down 71.59% YoY), while the FY2021 annual figure was $30671.8, down 71.56% from the prior year.
- Amortization of Deferred Charges eased to $30369.8 in Q1 2021, from $35226.2 in the prior quarter.
- Over the last five years, Amortization of Deferred Charges for AVCRF reached as high as $59601.0 in Q2 2020 and fell as low as -$22376.8 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | Avricore Health | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 30,369.83 |
| Mar 31, 2021 | 30,369.83 |
| Dec 31, 2020 | 35,226.22 |
| Dec 31, 2020 | 35,226.22 |
| Sep 30, 2020 | 34,461.71 |
| Sep 30, 2020 | 34,461.71 |
| Jun 30, 2020 | 59,601.02 |
| Jun 30, 2020 | 59,601.02 |
| Mar 31, 2020 | -22,376.84 |
| Mar 31, 2020 | -22,376.84 |